A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.
Authors: Samiotaki G, Vlachos F, Tung YS, Konofagou EE
Focused ultrasound in conjunction with the systemic administration of microbubbles has been shown to open the blood-brain barrier (BBB) selectively, noninvasively and reversibly. In this study, we investigate the dependence of the BBB opening's reversibility on the peak-rarefactional pressure (0.30-0.60 MPa) as well as the microbubble size (diameters of 1-2, 4-5, or 6-8 μm) in mice using contrast-enhanced T(1)-weighted (CE-T(1)) MR images (9.4 T). Volumetric measurements of the diffusion of Gd-DTPA-BMA into the brain parenchyma were used for the quantification of the BBB-opened region on the day of sonication and up to 5 days thereafter. The volume of opening was found to increase with both pressure and microbubble diameter. The duration required for closing was found to be proportional to the volume of opening on the day of opening, and ranged from 24 h, for the smaller microbubbles, to 5 days at high peak-rarefactional pressures. Overall, larger bubbles did not show significant differences. Also, the extent of BBB opening decreased radially towards the focal region until the BBB's integrity was restored. In the cases where histological damage was detected, it was found to be highly correlated with hyperintensity on the precontrast T(1) images.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To investigate how peak-rarefactional pressure and microbubble size affect the volume and reversibility (duration to close) of focused ultrasound–induced blood–brain barrier opening in mice using contrast-enhanced MRI.
Animal model / Human subject
Mouse (Mus musculus), strain None, age None, sex None
Disease model
healthy
MRI or image guidance method
Guided using 9.4 T MRI with contrast-enhanced T1-weighted (CE-T1) imaging for targeting and volumetric measurement of the BBB-opened region
Cargo name and characteristics
Gd-DTPA-BMA — a small-molecule, gadolinium-based MRI contrast agent (extracellular, nonionic chelate) used to visualize and quantify BBB opening by contrast-enhanced T1-weighted MRI
Route of administration
intravenous (systemic administration of microbubbles and Gd-DTPA-BMA)
Outcomes and Safety
Summary of Outcomes
Focused ultrasound with systemically administered microbubbles produced blood–brain barrier openings whose volume increased with peak-rarefactional pressure and microbubble size, with closure time proportional to initial opening volume (ranging from 24 hours to 5 days) and histological damage correlating with pre-contrast T1 hyperintensity.
Duration of biological effect
24 hours to 5 days
Safety-related matter
Some cases showed histological damage, which was highly correlated with hyperintensity on pre-contrast T1 images.
Brain Region
Ultrasound Parameters
Ultrasound instrument
None.
FUS Intensity
3.0 - 12.0 W/cm2 (calculated from PRP 0.30–0.60 MPa)
FUS Pressure
0.30 MPa - 0.60 MPa
FUS Mode
pulsed
Duration of a single FUS session
24 hours to 5 days
Treatment frequency
single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search